Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1983 Sep;48(3):341–348. doi: 10.1038/bjc.1983.198

Multivariate analyses as aids to diagnosis and assessment of prognosis in gastrointestinal cancer.

J de Mello, L Struthers, R Turner, E H Cooper, G R Giles
PMCID: PMC2011475  PMID: 6688531

Abstract

The role of carcinoembryonic antigen (CEA), gamma glutamyl transpeptidase (gamma GT), phosphohexose isomerase (PHI), pseudouridine (psi) and acute phase reactant proteins (C-reactive protein (CRP) alpha 1-antichymotrypsin (ACT) and alpha 1-acid glycoprotein (AGP] in assessing the prognosis of gastrointestinal neoplasms and the discriminant function in distinguishing benign from malignant diseases of the GI tract was examined. In stomach cancer pre-operative levels of CRP can help in the identification of the patients with a resectable tumour; the pre-operative biochemical measurements do not give any further information on prognosis once stage and site are taken into account. In colorectal cancer pre-operative ACT levels give additional prognostic information once the clinical factors, Dukes stage, sex and age have been accounted for; PHI levels are on the border line of significance. A discriminant function has been devised using sex, CEA, psi, gamma GT, ACT and PHI that can identify 89% of Dukes "D" patients prior to surgery with a misclassification of 7% of other cases of colorectal cancer. A discriminant function using all the biochemical variates separated the cancer from non-cancer patients. The false positive rate for cancer was 16% and a false negative rate of 19%, when the cut-off level was set at 0.7.

Full text

PDF
341

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albert A. On the use and computation of likelihood ratios in clinical chemistry. Clin Chem. 1982 May;28(5):1113–1119. [PubMed] [Google Scholar]
  2. Breslow N. Covariance analysis of censored survival data. Biometrics. 1974 Mar;30(1):89–99. [PubMed] [Google Scholar]
  3. Cooper E. H., Stone J. Acute phase reactant proteins in cancer. Adv Cancer Res. 1979;30:1–44. doi: 10.1016/s0065-230x(08)60893-3. [DOI] [PubMed] [Google Scholar]
  4. Davis G. E., Suits R. D., Kuo K. C., Gehrke C. W., Waalkes T. P., Borek E. High-performance liquid chromatographic separation and quantitation of nucleosides in urine and some other biological fluids. Clin Chem. 1977 Aug;23(8):1427–1435. [PubMed] [Google Scholar]
  5. Finlay I. G., McArdle C. S. The identification of patients at high risk following curative resection for colorectal carcinoma. Br J Surg. 1982 Oct;69(10):583–584. doi: 10.1002/bjs.1800691008. [DOI] [PubMed] [Google Scholar]
  6. Goslin R., Steele G., Jr, Macintyre J., Mayer R., Sugarbaker P., Cleghorn K., Wilson R., Zamcheck N. The use of preoperative plasma CEA levels for the Stratification of patients after curative resection of colorectal cancers. Ann Surg. 1980 Dec;192(6):747–751. doi: 10.1097/00000658-198012000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Haesen J. P., Berends G. T., Zondag H. A. An automated method for the determination of serum -glutamyltranspeptidase. Clin Chim Acta. 1972 Mar;37:463–470. doi: 10.1016/0009-8981(72)90470-6. [DOI] [PubMed] [Google Scholar]
  8. Higley B., De Mello J., Jr, Oakes D. J., Giles G. R. Urinary pseudouridine/creatinine ratio as an indicator of gastrointestinal cancer. Br J Surg. 1982 Dec;69(12):699–701. doi: 10.1002/bjs.1800691204. [DOI] [PubMed] [Google Scholar]
  9. Kushner I. The phenomenon of the acute phase response. Ann N Y Acad Sci. 1982;389:39–48. doi: 10.1111/j.1749-6632.1982.tb22124.x. [DOI] [PubMed] [Google Scholar]
  10. Mancini G., Carbonara A. O., Heremans J. F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965 Sep;2(3):235–254. doi: 10.1016/0019-2791(65)90004-2. [DOI] [PubMed] [Google Scholar]
  11. O'Quigley J., Haworth S., Cooper E. H., Haije W., van der Werf-Messing B., Richards B., Robinson M. R. Prognostic significance of serum proteins in invasive bladder cancer. A preliminary report of the E.O.R.T.C. Urological Group. Eur J Cancer. 1981 Feb;17(2):251–255. doi: 10.1016/0014-2964(81)90044-x. [DOI] [PubMed] [Google Scholar]
  12. Podolsky D. K., Weiser M. M., Isselbacher K. J., Cohen A. M. A cancer-associated galactosyltransferase isoenzyme. N Engl J Med. 1978 Sep 28;299(13):703–705. doi: 10.1056/NEJM197809282991306. [DOI] [PubMed] [Google Scholar]
  13. Staab H. J., Anderer F. A., Brümmendorf T., Hornung A., Fischer R. Prognostic value of preoperative serum CEA level compared to clinical staging: II. Stomach cancer. Br J Cancer. 1982 May;45(5):718–727. doi: 10.1038/bjc.1982.113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Staab H. J., Anderer F. A., Brümmendorf T., Stumpf E., Fischer R. Prognostic value of preoperative serum CEA level compared to clinical staging. I. Colorectal carcinoma. Br J Cancer. 1981 Nov;44(5):652–662. doi: 10.1038/bjc.1981.250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Steele G., Jr, Ellenberg S., Ramming K., O'Connell M., Moertel C., Lessner H., Bruckner H., Horton J., Schein P., Zamcheck N. CEA monitoring among patients in multi-institutional adjuvant G.I. therapy protocols. Ann Surg. 1982 Aug;196(2):162–169. doi: 10.1097/00000658-198208000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Szymendera J. J., Nowacki M. P., Szawłowski A. W., Kamińska J. A. Predictive value of plasma CEA levels: preoperative prognosis and postoperative monitoring of patients with colorectal carcinoma. Dis Colon Rectum. 1982 Jan-Feb;25(1):46–52. doi: 10.1007/BF02553548. [DOI] [PubMed] [Google Scholar]
  17. Wanebo H. J., Rao B., Pinsky C. M., Hoffman R. G., Stearns M., Schwartz M. K., Oettgen H. F. Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. N Engl J Med. 1978 Aug 31;299(9):448–451. doi: 10.1056/NEJM197808312990904. [DOI] [PubMed] [Google Scholar]
  18. Ward A. M., Cooper E. H., Turner R., Anderson J. A., Neville A. M. Acute-phase reactant protein profiles: an aid to monitoring large bowel cancer by CEA and serum enzymes. Br J Cancer. 1977 Feb;35(2):170–178. doi: 10.1038/bjc.1977.24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. te Velde E. R., Berrens L., Zegers B. J., Ballieux R. E. Acute phase reactants and complement components as indicators of recurrence in human cervical cancer. Eur J Cancer. 1979 Jun;15(6):893–899. doi: 10.1016/0014-2964(79)90231-7. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES